Osteoporosis News

Multivitamin and cocoa extract supplements do not protect against clinical fractures for older adults, according to data published in the Journal of Bone and Mineral Research.

The FDA has approved two new biosimilars of denosumab for all indications of the reference medications Prolia and Xgeva, according to a press release from Celltrion.

Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a BMD T-score of at least –2.8 at the total hip or –3.1 at the lumbar spine at baseline, according to study findings.

The FDA has approved two new biosimilars of denosumab to treat osteoporosis, increase bone mass, prevent skeletal-related events for people with multiple myeloma and other indications, Samsung Bioepis announced.

Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than those receiving placebo, according to trial findings published in The New England Journal of Medicine.

In a final recommendation statement, the U.S. Preventive Services Task Force said that all women aged 65 years and older should be screened for osteoporosis to prevent fractures.

Women with pregnancy and lactation-induced osteoporosis reported fewer disease-related fears or concerns after joining an online peer support group and sharing their health care experiences, researchers reported.

The risk for fractures among postmenopausal women may vary between ethnic origin groups, according to findings from the Women’s Health Initiative published in The Journal of Bone and Mineral Research.

Pregnancy and lactation-associated osteoporosis incidence was greater than previously reported, suggesting potentially overlooked patients, with vertebral fracture the most common type of premenopausal osteoporosis, researchers reported.